Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

223
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
223
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

200
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
200
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

288
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
288
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

106
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
106
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

159
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
159
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

99
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Influencing Nurses' Participation in Voluntary-Assisted Dying: A National Cross-Sectional Study.

Journal of advanced nursing·2026
Same author

Interventions to Reduce Burden Among Informal Caregivers of People With Chronic Kidney Disease: Systematic Review and Meta-Analysis.

Journal of renal care·2026
Same author

Multimodal Strategies for Improving Health Literacy in Adults with CKD.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Remote symptom assessment and management via mobile app for adults with chronic kidney disease in Vietnam (SAM-CKD programme): a randomised feasibility trial protocol.

BMJ open·2026
Same author

Advance Care Planning Interventions for Adults With Chronic Kidney Disease: A Systematic Review.

Journal of renal care·2026
Same author

Hospital-community partnership to implement community-based health improvement.

Journal of public health research·2026

Related Experiment Video

Updated: Oct 29, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.5K

A cross-sectional study exploring cognitive impairment in kidney failure.

Pauline Nicholas1,2, Theresa Green3,4, Louise Purtell1,5,6

  • 1Kidney Health Service, Metro North Hospital and Health Service, Brisbane, Australia.

Journal of Renal Care
|July 6, 2021
PubMed
Summary

Cognitive impairment affects 34% of people with kidney failure, with higher rates in advanced stages. Factors like age, diabetes, and hypertension are associated with this condition, impacting decision-making.

Keywords:
Montreal Cognitive Assessmentcognitive impairmentend stage kidney diseasekidney failurekidney replacement therapy

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.0K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.2K

Related Experiment Videos

Last Updated: Oct 29, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.5K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.0K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.2K

Area of Science:

  • Nephrology
  • Neuroscience
  • Public Health

Background:

  • Cognitive impairment prevalence and factors in kidney failure are poorly understood.
  • Cognitive assessment is crucial for patient understanding and decision-making regarding treatment.

Purpose of the Study:

  • To determine the prevalence of cognitive impairment in individuals with kidney failure.
  • To identify factors associated with cognitive impairment in this population.

Main Methods:

  • A prospective cross-sectional study involving 222 participants with chronic kidney disease grade 5 (CKD G5).
  • Cognitive function assessed using the Montreal Cognitive Assessment (MoCA).
  • Data on demographics, anxiety, depression, kidney disease type, and comorbidities were collected.

Main Results:

  • The prevalence of cognitive impairment was 34%, significantly higher in CKD G5 patients.
  • Associated factors included older age, diabetes, hypertension, lower education, and specific biomarkers (hemoglobin, albumin, parathyroid hormone).
  • Longer duration of treatment also correlated with cognitive impairment.

Conclusions:

  • Cognitive impairment is common in kidney failure, affecting informed decision-making and treatment choices.
  • Routine cognitive function assessment should be integrated into clinical practice for kidney failure patients.